QoL good for MGMT-methylated glioblastoma patients with lomustine-temozolideJanuary 2, 2020Neuro-oncology
Researchers seek a way to predict cognitive deficits in children treated for ALLNovember 15, 2019PediatricsNeuro-oncology
Tandem transplants provide EFS edge in pediatric neuroblastomaAugust 29, 2019PediatricsNeuro-oncology
Treatment for pediatric low-grade glioma is associated with poor cognitive and socioeconomic outcomesJune 29, 2019PediatricsNeuro-oncology
Proposed neuroblastoma classification scheme hinges on telomere maintenance mechanismsDecember 6, 2018Neuro-oncology
CNS lymphoma guidelines stress patient fitness, not age, in choosing treatmentNovember 30, 2018Neuro-oncology
Immunotherapies extend survival for melanoma patients with brain metastasesJuly 12, 2018Neuro-oncology
Recombinant poliovirus appears safe, active as recurrent glioblastoma treatmentJuly 10, 2018Neuro-oncology
FDA: Gadolinium retention prompts new GBCA class warning, safety measuresDecember 21, 2017Neuro-oncologyMultiple Sclerosis
FDA: Gadolinium retention prompts new GBCA class warning, safety measuresDecember 20, 2017Neuro-oncologyMultiple Sclerosis
